Rüdiger oppermann - neues aus harfistan - B-Cell Depletion with Rituximab in Relapsing–Remitting.


 · In a phase 2, double-blind, 48-week trial involving 104 patients with relapsing–remitting multiple sclerosis, we assigned 69 patients to receive 1000 mg ...


Rüdiger Oppermann - Neues Aus HarfistanRüdiger Oppermann - Neues Aus HarfistanRüdiger Oppermann - Neues Aus HarfistanRüdiger Oppermann - Neues Aus Harfistan

bc.vegasgame.info